Compare EVO & EMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVO | EMO |
|---|---|---|
| Founded | 1993 | 2011 |
| Country | Germany | United States |
| Employees | 4553 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 994.5M | 1.0B |
| IPO Year | N/A | N/A |
| Metric | EVO | EMO |
|---|---|---|
| Price | $2.88 | $49.35 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | 29.8K | ★ 44.0K |
| Earning Date | 04-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.70% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.37 | N/A |
| Revenue Next Year | $10.05 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.31 | $41.54 |
| 52 Week High | $4.42 | $54.90 |
| Indicator | EVO | EMO |
|---|---|---|
| Relative Strength Index (RSI) | 57.27 | 44.41 |
| Support Level | $2.88 | $48.25 |
| Resistance Level | $3.30 | $51.71 |
| Average True Range (ATR) | 0.06 | 0.78 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 91.89 | 40.71 |
Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.
ClearBridge Energy Midstream Opportunity Fund Inc is a non-diversified, closed-end management investment company. Its investment objective is to provide long-term investors with a high level of total return with an emphasis on cash distributions. The Fund considers investments in midstream entities as those entities that provide midstream services including the gathering, transporting, processing, fractionation, storing, refining, and distribution of oil, natural gas liquids and natural gas.